Search results
A Man Had Covid For 613 Straight Days—and Created a Whole New Mutation
Popular Mechanics via Yahoo News· 3 days agoWhen the world first woke up to the seriousness of the COVID-19 pandemic, the SARS-CoV-2 coronavirus...
Scientists discover higher levels of CO₂ increase survival of viruses in the air and transmission...
Phys.org· 3 days agoThe research, led by the University of Bristol and published today in Nature Communications, shows how CO2 is a major factor in prolonging the life of SARS-CoV< ...
A Man Had Covid For 613 Straight Days—and Created a Whole New Mutation
Popular Mechanics· 3 days agoWhen the world first woke up to the seriousness of the COVID-19 pandemic, the SARS-CoV-2 coronavirus...
Man dies after 613-day COVID-19 infection that underwent 50 mutations
Scripps News via AOL· 7 days agoAccording to the study, the man, whose identity was not disclosed, suffered from a blood disorder....
A Scientist Says He Has the Evidence That We Live in a Simulation
Prevention via Yahoo News· 5 hours agoThis last one is where Vopson makes a big claim: contrary to Charles Darwin’s idea that mutations...
EXCLUSIVE: Virax Biolabs Launches Immune Profiling Solutions To Evaluate Adaptive Immunity In...
Investing.com· 4 days agoEXCLUSIVE: Virax Biolabs Launches Immune Profiling Solutions To Evaluate Adaptive Immunity In...
Engineers muffle invading pathogens with a 'molecular mask'
Phys.org· 5 days agoThe peptides that make up this gel prevent viruses such as SARS-CoV-2, which causes COVID-19, from attaching to and entering cells. Over ...
COVID-19 virus disrupts protein production: Researcher discusses her recent findings
Phys.org· 5 days agoOne thing we do know: Following infection, it's critical that our cells make new proteins to defend against the virus. Writer Jenni Bozec recently spoke with Yerlici—who is based in the lab ...
Are Monoclonal Antibodies the Future of Long COVID Treatments?
Technology Networks· 7 days agoOne study published in PLOS Pathogens in 2022 found that long COVID patients had 100 times the...
BioVie secures $13.1M funding from US Department of Defense for Long COVID treatment
Proactive Investors· 7 hours agoBioVie Inc (NASDAQ:BIVI), a clinical-stage company focused on innovative drug therapies, announced...